XNCR NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Xencor Inc · Healthcare · Biotechnology

Latest close 20.21 USD
4.0% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 52.8% above the Trend Line and sits at 89.6% of its 52-week range. The latest completed week returned 4.0%, after a 34.7% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 52/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 3d.

Setup score 62 out of 100
Latest Close 20.21 USD 31 Jul 2026
1W Return 4.0% latest completed week
4W Return 34.7% short-term follow-through
12W Return 57.2% quarterly tape
Trend Breadth 36.5% 19 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 43.88% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 52.8% above the Trend Line and sits at 89.6% of its 52-week range. The latest completed week returned 4.0%, after a 34.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5912-week average 0.31

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 34.7% over four weeks, 57.2% over 12 weeks, and 153.3% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W4.0%
4W34.7%
12W57.2%
26W67.2%
52W153.3%
Active trend streak3 weeks
Active weeks in one year19
Trend breadth36.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.80Latest activity-pressure read.
Pressure change92.6%Four-week change in activity pressure.
Leadership42.81Latest relative-leadership reading.
RS change558.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength18/100Blend of value, momentum, and quality. Underlying universe rank 83; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality2/100Profitability and accounting quality. Underlying universe rank 99; rank 1 is best.
Momentum93/100Medium-term price momentum. Underlying universe rank 8; rank 1 is best.
Growth13/100Revenue and earnings growth. Underlying universe rank 88; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
14.8x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-11.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
36.2%
Gross profit retained from each unit of revenue.
Operating margin
-145.9%
Operating profit retained from revenue.
Free-cash-flow margin
-189.2%
Free cash flow generated from revenue.
Return on invested capital
-15.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-29.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

XNCR shows bullish options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 8.8%, and Sharemaestro trend signal active.

Conviction52/100
Expected move8.8%
Put/call volume0.00
Pressure100
Speculation5
Volatility61
Trend agreement10
Open options detail
Insider activity16 / 4

16 acquisitions and 4 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 58 relevant articles.

17 positive · 32 neutral · 9 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move8.8%Nearest-chain priced movement where available.
52-week drawdown-7.1%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+19.1%Week of 26 Jun.
Worst week-12.8%Week of 15 May.
Latest week+4.0%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks0
Modest losses8
Sharp losses3
Recent vol7.2%13-week weekly-return volatility.
Base vol7.5%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew7.7% / -4.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202620.21 USD4.0%13.23 USD16.55 USD1.8042.815.9MOn
24 Jul 202619.44 USD11.3%13.05 USD16.58 USD1.7040.087.4MOn
17 Jul 202617.47 USD10.2%12.91 USD16.60 USD1.6025.304.1MOn
10 Jul 202615.85 USD5.7%12.85 USD16.65 USD1.319.914.4MOff
3 Jul 202615.00 USD-0.3%12.87 USD16.71 USD0.936.514.2MOff
26 Jun 202615.05 USD19.1%12.94 USD16.76 USD0.518.406.0MOff
19 Jun 202612.64 USD2.5%13.02 USD16.83 USD0.06-12.514.4MOff
12 Jun 202612.33 USD4.8%13.13 USD16.91 USD-0.10-12.303.5MOff
5 Jun 202611.77 USD-0.9%13.21 USD17.00 USD-0.17-14.393.7MOff
29 May 202611.88 USD5.0%13.29 USD17.10 USD0.01-17.612.0MOff
22 May 202611.31 USD0.8%13.38 USD17.20 USD0.18-19.243.7MOff
15 May 202611.22 USD-12.8%13.44 USD17.30 USD0.25-18.843.7MOff
8 May 202612.86 USD1.3%13.56 USD17.40 USD0.35-7.254.7MOff
1 May 202612.69 USD-2.2%13.57 USD17.49 USD0.17-3.364.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.